Tandem Diabetes Care Inc
NASDAQ:TNDM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
US |
|
SAP SE
F:SAP
|
DE |
|
Societe Generale SA
PAR:GLE
|
FR |
|
C
|
Core Laboratories Inc
F:HJ1
|
US |
|
E
|
Ethos Ltd
NSE:ETHOSLTD
|
IN |
|
H
|
Hecla Mining Co
XMUN:HCL
|
US |
|
U
|
UnitedHealth Group Inc
SWB:UNH
|
US |
|
Siemens Healthineers AG
F:SHL
|
DE |
|
Tesmec SpA
F:2GV
|
IT |
|
A
|
Aegean Airlines SA
LSE:0OHY
|
GR |
|
T
|
Trupanion Inc
F:TPW
|
US |
|
C
|
CVR Energy Inc
SWB:FL9
|
US |
|
P
|
Prudential PLC
SWB:PRU
|
UK |
Wall St Price Targets
TNDM Price Targets Summary
Tandem Diabetes Care Inc
According to Wall Street analysts, the average 1-year price target for TNDM is 29.45 USD with a low forecast of 15.66 USD and a high forecast of 52.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TNDM's stock price target?
Price Target
29.45
USD
According to Wall Street analysts, the average 1-year price target for TNDM is 29.45 USD with a low forecast of 15.66 USD and a high forecast of 52.5 USD.
What is the Revenue forecast for Tandem Diabetes Care Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for Tandem Diabetes Care Inc?
Projected CAGR
14%
The compound annual growth rate for Gross Profit over the next 5 years is 14%.
